Prof. Dr. Bernd Wullich



Organisationseinheit


Lehrstuhl für Urologie


Publikationen (Download BibTeX)

Go to first page Go to previous page 1 von 10 Go to next page Go to last page

Wach, S., Brandl, M., Borchardt, H., Weigelt, K., Lukat, S., Nolte, E.,... Aigner, A. (2019). Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer Cells In Vitro and In Vivo. Molecular Therapy - Nucleic Acids, 16, 272-283. https://dx.doi.org/10.1016/j.omtn.2019.02.020
Wullich, B., & Wiedemann, A. (2019). Geriatric urology (Geriatrische Urologie). Urologe, 58(4), 369-. https://dx.doi.org/10.1007/s00120-019-0912-7
Polifka, I., Agaimy, A., Herrmann, E., Spath, V., Trojan, L., Stoeckle, M.,... Hartmann, A. (2019). High proliferation rate and TNM stage but not histomorphological subtype are independent prognostic markers for overall survival in papillary renal cell carcinoma. Human Pathology, 83, 212-223. https://dx.doi.org/10.1016/j.humpath.2018.08.006
Eckstein, M., Erben, P., Kriegmair, M.C., Worst, T.S., Weiss, C.-A., Wirtz, R.M.,... Erlmeier, F. (2019). Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab. European journal of cancer, 106, 234-243. https://dx.doi.org/10.1016/j.ejca.2018.11.007
Stoehr, C.G., Steffens, S., Polifka, I., Jung, R., Kahlmeyer, A., Ivanyi, P.,... Taubert, H. (2019). Piwi-like 1 protein expression is a prognostic factor for renal cell carcinoma patients. Scientific Reports, 9. https://dx.doi.org/10.1038/s41598-018-38254-3
Kahlmeyer, A., Goebell, P., & Wullich, B. (2019). Presurgical assessments (Assessments vor Operationen). Urologe, 58(4), 373-380. https://dx.doi.org/10.1007/s00120-019-0888-3
Kahlmeyer, A., Goebell, P., & Wullich, B. (2019). Presurgical assessments. Urologe, 58(4), 373-380. https://dx.doi.org/10.1007/s00120-019-0888-3
Taubert, H., Becker, C., Borkowetz, A., Seitz, G., Kristiansen, G., Wach, S., & Wullich, B. (2018). 15th annual conference of the DPKK. Urologe, 57(8), 966-968. https://dx.doi.org/10.1007/s00120-018-0710-7
Schmidkonz, C., Cordes, M., Schmidt, D., Bäuerle, T., Goetz, T.I., Beck, M.,... Ritt, P. (2018). 68Ga-PSMA-11 PET/CT-derived metabolic parameters for determination of whole-body tumor burden and treatment response in prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. https://dx.doi.org/10.1007/s00259-018-4042-z
Schmidkonz, C., Hollweg, C., Beck, M., Reinfelder, J., Götz, T., Sanders, J.,... Ritt, P. (2018). 99m Tc-MIP-1404-SPECT/CT for the detection of PSMA-positive lesions in 225 patients with biochemical recurrence of prostate cancer. Prostate, 78(1), 54-63. https://dx.doi.org/10.1002/pros.23444

Zuletzt aktualisiert 2016-05-05 um 05:06